Understanding how fetal skin heals without scars
Official title: Mechanisms of Fetal Skin Regeneration
Funded at Harvard University · NIH-10943887 · Data updated 2026-11-12
This study is looking at how baby mice can heal their skin without scars, and it hopes to find out how this amazing ability works so that we can help adults heal better from skin injuries too.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $497,083 |
| NIH project number | 1R01AR084566-01 |
| Project ID | NIH-10943887 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals with skin injuries or conditions that result in scarring.
✕Less likely to help
Patients with fully healed skin or those who do not have skin injuries may not receive any benefit from this research.
What this research studies
This research investigates the unique ability of fetal skin to heal from injuries without forming scars, a capability that diminishes as mammals mature. By studying fetal mice, researchers aim to uncover the genetic and molecular mechanisms that enable this scarless regeneration. The project employs advanced techniques such as in utero surgical procedures, single-cell RNA analysis, and targeted genetic manipulation using viral vectors to explore these regenerative processes. The findings could provide insights into improving healing in adults and developing new therapies for skin injuries.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance healing and reduce scarring in patients with skin injuries.
How similar studies have gone: Previous research has shown promise in understanding regenerative mechanisms in other organs, but the specific approach to fetal skin regeneration is relatively novel.
Where this research is happening
-
Harvard University
Cambridge, United States Active
Researchers
- Principal investigator: Hsu, Ya-Chieh — Harvard University
- Study coordinator: Hsu, Ya-Chieh
Related research
Other NIH-funded projects on the same topics.
-
Using biomaterials to boost T cell immunity against cancer
This study is exploring new ways to boost the immune system's T cells, which help fight cancer, by using special materials to create artificial cells that can better activate them, with the hope of developing improved treatments for cancer patients.
-
Understanding how venom glands develop to reveal new medicines
A Corsortium at Harvard studies how venom glands form and work in different animals to uncover new ways to create and use powerful medicines for human health.
-
Muscle Mass: a Key Missing Piece in How We Model Movement
This project studies how adding muscle mass to computer models changes predictions of movement, aiming to improve mobility for people of all ages.
-
Synthetic circuit tools to precisely control human immune cells
Aims to design safe, programmable gene circuits that can steer human immune cells for better therapies.
-
HPF-X: A fast, buffer-exchanging high-pressure freezing tool for capturing rapid cellular events
A new tool called HPF-X will let scientists freeze cells at precise moments after stimulation, so we can see rapid molecular changes in neuroscience and related fields.
-
Pathways and factors to prevent early-onset colorectal tumors
This NIH grant would explore why colorectal cancer is rising in people under 50 and identify clues we can use to prevent it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.